newsThe Access to COVID-19 Tools (ACT) Accelerator reports that new…
30 September 2020 | By Hannah Balfour (European Pharmaceutical Review)
The Access to COVID-19 Tools (ACT) Accelerator reports that new agreements have made millions of rapid COVID-19 antigen tests available to low and middle-income countries.